###begin article-title 0
###xml 44 49 <span type="species:ncbi:10090">Mouse</span>
Cross Species Genomic Analysis Identifies a Mouse Model as Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma
###end article-title 0
###begin p 1
Conceived and designed the experiments: DL SM DGK. Performed the experiments: JKM RDD LMS WCE FJH SY BEB. Analyzed the data: JKM RFR LD GL AJFL. Contributed reagents/materials/analysis tools: LD TJ DL. Wrote the paper: JKM DGK.
###end p 1
###begin p 2
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 225 234 225 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 206 234 206 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 420 425 420 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxm1</italic>
###xml 678 682 678 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 687 696 687 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 670 696 670 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; p53<sup>Flox/Flox</sup></italic>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 318 323 <span type="species:ncbi:10090">mouse</span>
###xml 395 400 <span type="species:ncbi:9606">human</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 639 644 <span type="species:ncbi:9606">human</span>
###xml 697 702 <span type="species:ncbi:10090">mouse</span>
Undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH) is one of the most common subtypes of human soft tissue sarcoma. Using cross species genomic analysis, we define a geneset from the LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma that is highly enriched in human MFH. With this mouse geneset as a filter, we identify expression of the RAS target FOXM1 in human MFH. Expression of Foxm1 is elevated in mouse sarcomas that metastasize to the lung and tissue microarray analysis of human MFH correlates overexpression of FOXM1 with metastasis. These results suggest that genomic alterations present in human MFH are conserved in the LSL-KrasG12D; p53Flox/Flox mouse model of soft tissue sarcoma and demonstrate the utility of this pre-clinical model.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Ozzello1">[1]</xref>
###xml 759 762 759 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Fletcher1">[2]</xref>
###xml 764 767 764 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Fletcher2">[3]</xref>
###xml 769 772 769 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Hollowood1">[4]</xref>
###xml 847 852 <span type="species:ncbi:10090">mouse</span>
###xml 1015 1023 <span type="species:ncbi:9606">patients</span>
###xml 1088 1093 <span type="species:ncbi:10090">mouse</span>
###xml 1146 1154 <span type="species:ncbi:9606">patients</span>
Malignant Fibrous Histiocytoma was first described in the 1960s and quickly became the most commonly diagnosed adult soft tissue sarcoma [1]. Because these tumors do not appear to arise from histiocytes, the term Malignant Fibrous Histiocytoma has recently fallen out of favor and many pathologists now classify these tumors as undifferentiated pleomorphic sarcomas. Despite this change in nomenclature, undifferentiated pleomorphic sarcoma (referred to here as MFH) remains one of the most common adult soft tissue sarcomas encountered in the clinic. However, the cell(s) of origin of MFH is unknown. Indeed, some have suggested that MFH is a collection of undifferentiated mesenchymal tumors sharing a common morphology rather than a single clinical entity [2], [3], [4]. This debate could be clarified by identifying the cell(s) of origin of a mouse model for MFH. Whether MFH describes a cancer that is a single pathogenic entity or an undifferentiated state shared by several sarcoma subtypes, the survival of patients with MFH has not improved for decades. Therefore, identifying a mouse model of MFH may also lead to better treatments for patients with this diagnosis.
###end p 4
###begin p 5
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kras</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trp53</italic>
###xml 287 290 287 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Kirsch1">[5]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
Human MFH is characterized by a propensity to metastasize to the lungs and by a range of histologic appearances including spindle and pleomorphic cells. Although these features are recapitulated in a mouse model of soft tissue sarcoma initiated by conditional mutations in Kras and Trp53[5], it is not clear whether this model is most similar to human MFH or another soft tissue sarcoma. Therefore, we sought to more accurately classify the sarcoma subtype for this mouse model using gene expression profiling.
###end p 5
###begin title 6
Methods
###end title 6
###begin title 7
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Genotyping, Tumor Generation, and Determination of Metastatic Potential
###end title 7
###begin p 8
###xml 87 90 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Kirsch1">[5]</xref>
###xml 288 289 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 5 10 <span type="species:ncbi:10090">mouse</span>
Both mouse genotyping and generation of tumors was carried out as described previously [5] in accordance with Duke University and MIT Institutional Animal Care and Use Committee approved protocols. Sarcomas were induced in the lower left limb and allowed to grow until approximately200 mm3 in volume. Tumors were then surgically excised via amputation of the limb and animals followed for a minimum of 4 months to determine the metastatic potential of the primary tumor.
###end p 8
###begin title 9
RNA Isolation
###end title 9
###begin p 10
###xml 31 35 31 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 42 51 42 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 23 51 23 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
RNA was extracted from LSL-KrasG12D; Trp53Flox/Flox tumors or normal muscle using TRIzol reagent (Invitrogen) and was purified using RNeasy mini kit (Qiagen).
###end p 10
###begin title 11
Microarray Processing and Analysis
###end title 11
###begin p 12
###xml 29 53 29 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s001">supplementary methods S1</xref>
###xml 224 227 224 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Bolstad1">[6]</xref>
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Irizarry1">[7]</xref>
Full details can be found in supplementary methods S1. Briefly, gene expression was determined using Affymetrix 430A 2.0 arrays (Affymetrix) as described in detail online (). CEL files were processed using the RMA algorithm [6], [7] to normalize the data. Genesets were identified using a signal-to-noise metric.
###end p 12
###begin p 13
###xml 25 28 25 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Baird1">[8]</xref>
###xml 30 33 30 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Subramanian1">[11]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">Mouse</span>
Human and Mouse datasets [8], [9], [10] were downloaded from GEO (GSE6461, GSE6481, GSE2553, and GDS1209), normalized with RMA (when appropriate). Genesets and array data were used in GSEA as described previously [11]. Classes were defined as one soft tissue sarcoma subtype versus controls (other sarcoma or normal muscle) present in their respective datasets.
###end p 13
###begin title 14
Database Accession Numbers
###end title 14
###begin p 15
Microarray data was generated in conformity to MIAME guidelines and has been deposited in the GEO database under accession number GSE16779.
###end p 15
###begin title 16
Oncogenic Pathway Predictors
###end title 16
###begin p 17
###xml 35 38 35 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 40 44 40 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Johnson1">[12]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Bild1">[13]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human soft tissue sarcoma datasets [9], [10] were combined using ComBat [12] and normal tissue samples removed from the combined dataset. An oncogenic pathway classifier for Ras pathway activity was developed as described previously [13]. This classifier was used to compare undifferentiated pleiomorphic sarcoma/MFH samples (n = 29) against all other soft tissue sarcomas. Significance was determined using a non-parametric Mann-Whitney test.
###end p 17
###begin title 18
Histology and Immunohistochemistry and Image Analysis
###end title 18
###begin p 19
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 564 570 <span type="species:ncbi:9986">Rabbit</span>
All human samples were obtained from tissue repositories at Duke and MD Anderson. These samples were used in accordance with Duke and MD Anderson Cancer Center Institutional Review Board (IRB) approved protocols under a waiver of consent. Five micron thick sections were cut from formalin fixed paraffin embedded samples. Samples were subjected to standard hematoyxlin and eosin staining or immunohistochemistry. Immunohistochemistry was performed with the following antibodies: phospho-ERK (Invitrogen 29-2389) and FOXM1 (Abcam ab47808), using the Vectastain ABC Rabbit IgG kit with Vectastain Elite ABC Reagent (Vector Labs).
###end p 19
###begin p 20
Brightfield images of slides taken at 40x were used for analysis using Image Pro AMS v6.1. The counting module was trained using both positive and negative nuclear staining for phospho-ERK. A minimum of 3000 nuclei were counted per sample and a ratio between total nuclei with positive nuclei to total nuclei was determined using a minimal and maximal area of 100 and 1000 pixels respectively.
###end p 20
###begin title 21
Tissue Microarrays (TMAs)
###end title 21
###begin p 22
###xml 454 461 <span type="species:ncbi:9606">patient</span>
TMAs were generated at MD Anderson Cancer Center and contained a clinically annotated set of 214 soft tissue sarcoma samples including: 166 MFH/Unclassified sarcomas, 19 synovial sarcomas, 6 leiomyosarcomas, 8 pleomorphic liposarcomas, 8 myxoid liposarcomas, 6 atypical lipomatous tumors, and 1 dedifferentiated liposarcoma. TMAs were stained as above and scored semiquantitatively on a scale from 0-3+ by a musculoskeletal pathologist (L.D.) blinded to patient outcome. Scores were correlated with both diagnosis and clinical outcome.
###end p 22
###begin title 23
Statistical Analysis of TMAs
###end title 23
###begin p 24
Scoring of TMAs was correlated with diagnosis, and metastasis-free survival.
###end p 24
###begin p 25
Correlation of immunohistochemical staining with diagnosis was tested for normality using a chi-square test. This did not reach statistical significance, therefore comparison between MFH and other soft tissue sarcomas was performed using the non-parametric Mann-Whitney test.
###end p 25
###begin p 26
Metastasis free survival analysis was performed on MFH samples comparing 3+ staining to 0-2+ staining. Survival was determined by Kaplan-Meier analysis.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 42 46 42 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 52 61 52 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 34 61 34 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-KRas<sup>G12D</sup>;Trp53<sup>Flox/Flox</sup></italic>
###xml 62 67 <span type="species:ncbi:10090">Mouse</span>
Cross-Species Genomic Analysis of LSL-KRasG12D;Trp53Flox/Flox Mouse Model of Soft Tissue Sarcoma
###end title 28
###begin p 29
###xml 179 186 179 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g001">Fig. 1A</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Haldar1">[14]</xref>
###xml 436 444 436 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s002">Table S1</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Subramanian1">[11]</xref>
###xml 574 577 574 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Baird1">[8]</xref>
###xml 579 582 579 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 750 757 750 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s007">Fig. S1</xref>
###xml 759 767 759 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s003">Table S2</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Haldar1">[14]</xref>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
###xml 547 552 <span type="species:ncbi:9606">human</span>
###xml 675 680 <span type="species:ncbi:9606">human</span>
###xml 816 821 <span type="species:ncbi:10090">mouse</span>
We hypothesized that genes most differentially expressed between mouse sarcoma and normal muscle would provide a useful molecular signature to interrogate human sarcoma datasets (Fig. 1A). To test this approach, we first analyzed published gene expression data from a previously validated mouse model of synovial sarcoma [14]. After identifying a geneset of 100 genes highly overexpressed in synovial sarcoma compared to normal muscle (Table S1) we used Gene Set Enrichment Analysis (GSEA) [11] to probe gene expression data from three studies of human soft tissue sarcomas [8], [9], [10]. We demonstrated strong statistical enrichment (p<0.001, FDR<0.02) of this geneset in human synovial sarcomas, but not in other subtypes of soft tissue sarcoma (Fig. S1, Table S2). This result is in agreement with GSEA for the mouse model of synovial sarcoma that was previously reported [14].
###end p 29
###begin title 30
Cross-species genomic comparison.
###end title 30
###begin p 31
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 62 63 62 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 88 96 88 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FloxFlox</sup>
###xml 69 96 69 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>FloxFlox</sup></italic>
###xml 114 122 114 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s004">Table S3</xref>
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 334 335 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 370 378 370 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s005">Table S4</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:10090">mouse</span>
A, Schematic for cross species genomic comparison using GSEA. B, The LSL-KrasG12D; Trp53FloxFlox sarcoma geneset (Table S3) is highly enriched in human MFH in the Nakayama et al. soft tissue sarcoma dataset [10] [p = 0.0014; False Discovery Rate (FDR) = 0.012; Enrichment Score (ES) = 0.74; Normalized Enrichment Score (NES) = 2.09]. C, Conversely, a human MFH geneset (Table S4) is strongly enriched in the mouse model of soft tissue sarcoma (p<0.001, FDR<0.001, ES = 0.637 NES = 2.78).
###end p 31
###begin p 32
###xml 105 109 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 116 125 116 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 97 125 97 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 205 213 205 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s004">Table S3</xref>
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Baird1">[8]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008075-t001">Table 1</xref>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g001">Fig. 1B</xref>
###xml 448 451 448 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Baird1">[8]</xref>
###xml 453 456 453 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 577 585 577 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s005">Table S4</xref>
###xml 649 656 649 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g001">Fig. 1C</xref>
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 566 571 <span type="species:ncbi:9606">human</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
###xml 689 694 <span type="species:ncbi:10090">mouse</span>
###xml 713 718 <span type="species:ncbi:9606">human</span>
Having validated this approach, we identified a geneset of 100 genes highly overexpressed in the LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma (n = 17) compared to normal muscle (n = 4) (Table S3). When this geneset was analyzed in the three human datasets of soft tissue sarcoma [8], [9], [10], only MFH samples showed statistical enrichment (p = 0.001; FDR = 0.012) (Table 1, Fig. 1B). Enrichment was seen in all three datasets [8], [9], [10], which represent 325 sarcoma samples and two types of array platforms. Moreover, genesets derived from human MFH (Table S4) also enriched in the mouse sarcoma data (p<0.001; FDR<0.001) (Fig. 1C). These data indicate that this mouse sarcoma model and human MFH share common genomic features.
###end p 32
###begin title 33
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 40 49 40 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 21 49 21 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 111 119 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s004">Table S3</xref>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
GSEA results for the LSL-KrasG12D; Trp53Flox/Flox geneset derived from the mouse model of soft tissue sarcoma (Table S3).
###end title 33
###begin p 34
###xml 87 90 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Baird1">[8]</xref>
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 52 57 <span type="species:ncbi:9606">human</span>
The mouse sarcoma geneset was used to examine three human soft tissue sarcoma datasets [8], [9], [10]. Only undifferentiated pleomorphic sarcoma/MFH demonstrated statistically significant enrichment. Table denotes p-values with FDR in parentheses. Bolded results note significance with p<0.05; FDR<0.25. DNE = Did Not Enrich, dash marks represent insufficient data points to do comparison.
###end p 34
###begin title 35
###xml 36 41 <span type="species:ncbi:9606">Human</span>
Ras Pathway Activity Is Enriched in Human MFH
###end title 35
###begin p 36
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Leach1">[15]</xref>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Yoo1">[16]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Yoo2">[17]</xref>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAS</italic>
###xml 470 474 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Bild1">[13]</xref>
###xml 600 607 600 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g002">Fig. 2A</xref>
###xml 796 803 796 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s008">Fig. S2</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 278 283 <span type="species:ncbi:9606">human</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 623 628 <span type="species:ncbi:9606">human</span>
The initiating events of human MFH are not well understood. Previous studies have shown mutations in p53 occur in 36% of human MFH [15] while the rate of canonical RAS mutations in human MFH varies from 0-50% [16], [17]. We hypothesized that the RAS pathway may be activated in human MFH even in the absence of canonical RAS mutations. To explore a link between MFH and Ras, we utilized previously described oncogenic pathway predictors that correlate with RAS activity [13]. The Ras oncogenic signature is enriched in human MFH samples compared to a panel of other soft tissue sarcomas (p = 0.002) (Fig. 2A). Moreover, in human MFH (n = 8) lacking canonical RAS mutations, we observed nuclear staining of phospho-ERK by immunohistochemistry in greater than 30% of tumor cells in 7 of 8 samples (Fig. S2).
###end p 36
###begin title 37
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 4 16 4 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup></italic>
###xml 23 32 23 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 18 32 18 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trp53<sup>Flox/Flox</sup></italic>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
The LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma provides insight into human MFH.
###end title 37
###begin p 38
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 157 158 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxm1</italic>
###xml 351 352 351 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 182 188 <span type="species:ncbi:10090">murine</span>
###xml 438 443 <span type="species:ncbi:9606">human</span>
A, An oncogenic Ras signature is enriched in human MFH samples compared to other types of soft tissue sarcoma (p = 0.002, non-parametric Mann-Whitney test). B, Q-RT-PCR for Foxm1 in murine soft tissue sarcomas correlates with metastatic potential of primary tumors (p = 0.01, two-tailed student's T-test, scale bars represent one standard deviation). C, FOXM1 expression in a tissue microarray correlates with metastasis free survival in human MFH (p = 0.038).
###end p 38
###begin title 39
FoxM1 Is a Novel Marker of Metastasis in MFH
###end title 39
###begin p 40
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 45 54 45 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 26 54 26 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 490 498 490 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s006">Table S5</xref>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s009">Fig. S3</xref>
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 451 456 <span type="species:ncbi:9606">human</span>
###xml 469 474 <span type="species:ncbi:10090">mouse</span>
###xml 579 584 <span type="species:ncbi:10090">mouse</span>
Because human MFH and the LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma share common genomic features, we wanted to determine if these shared features could be used to identify diagnostic or prognostic factors for human MFH. As MFH is considered a diagnosis of exclusion, we initially attempted to identify a marker that is specific to MFH. We identified a panel of 10 candidate biomarkers based on their common upregulation in both human MFH and the mouse sarcoma model (Table S5). Expression of 9 of these candidates was validated in an independent cohort of mouse sarcomas by Q-RT-PCR (Fig. S3).
###end p 40
###begin p 41
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Liu1">[18]</xref>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Ma1">[19]</xref>
###xml 318 325 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s008">Fig. S2</xref>
###xml 551 558 551 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s010">Fig. S4</xref>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 703 708 <span type="species:ncbi:9606">human</span>
FOXM1, which is a member of the forkhead transcription factor family that enhances tumorigenesis in other solid tumors [18], was selected for further analysis because it is downstream of Ras[19]. Immunohistochemistry for FOXM1 in a panel of 8 human MFH samples demonstrated nuclear staining for FOXM1 in all 8 tumors (Fig. S2). We next analyzed the expression of FOXM1 in a clinically annotated tissue microarray (TMA) containing 166 MFH samples and 48 other soft tissue sarcomas. Although 84% of the MFH samples stained positive for FOXM1 (p = 0.02, Fig. S4), this marker was also expressed, but to a lesser degree, in other sarcoma subtypes. Therefore, FOXM1 may not be a useful diagnostic marker for human MFH.
###end p 41
###begin p 42
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Wang1">[20]</xref>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxm1</italic>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g002">Fig. 2B</xref>
###xml 531 538 531 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g002">Fig. 2C</xref>
###xml 603 611 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s006">Table S5</xref>
###xml 662 669 662 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s011">Fig. S5</xref>
###xml 266 272 <span type="species:ncbi:10090">murine</span>
###xml 389 394 <span type="species:ncbi:9606">human</span>
Because FoxM1 has previously been shown to regulate the expression of matrix metalloproteases MMP-2 and -9, which are key mediators of cell invasion [20], we hypothesized that high FOXM1 expression may correlate with metastasis. We measured Foxm1 gene expression in murine soft tissue sarcomas and found a correlation with the development of lung metastases (Fig. 2B, p = 0.01). Likewise, human MFH with high FOXM1 expression correlated with decreased metastasis-free survival compared to sarcomas with low to no FOXM1 expression (Fig. 2C). In contrast, overexpression of another candidate marker MELK (Table S5) did not correlate with metastasis-free survival (Fig. S5).
###end p 42
###begin title 43
Discussion
###end title 43
###begin p 44
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 121 130 121 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 102 130 102 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 548 552 548 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 559 568 559 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 540 568 540 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 669 672 669 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Kirsch1">[5]</xref>
###xml 819 826 819 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s012">Fig. S6</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 290 295 <span type="species:ncbi:9606">human</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
###xml 569 574 <span type="species:ncbi:10090">mouse</span>
###xml 659 664 <span type="species:ncbi:9606">human</span>
###xml 764 769 <span type="species:ncbi:10090">mouse</span>
###xml 782 787 <span type="species:ncbi:9606">human</span>
We used cross species genomic analysis to determine which human sarcoma subtype is represented by the LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma. We identified a geneset in the mouse sarcomas that is highly enriched in human MFH. This geneset was not enriched in other human sarcomas, such as fibrosarcoma or leiomyosarcoma, which can be difficult to distinguish from MFH. Furthermore, we have identified enrichment of Ras pathway activity in human MFH compared to other types of soft-tissue sarcoma. Additionally, the LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma has a propensity to metastasize to the lungs much like human MFH [5]. Based on this genomic analysis, the pattern of lung metastasis, and the similarity of the mouse sarcomas to human MFH at the histological level (Fig. S6), we conclude that this model closely resembles MFH.
###end p 44
###begin p 45
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Fletcher1">[2]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Fletcher2">[3]</xref>
###xml 147 150 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Hollowood1">[4]</xref>
###xml 374 379 <span type="species:ncbi:10090">mouse</span>
###xml 393 398 <span type="species:ncbi:9606">human</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
###xml 620 625 <span type="species:ncbi:9606">human</span>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
###xml 780 785 <span type="species:ncbi:9606">human</span>
We recognize that the diagnosis of undifferentiated pleomorphic sarcoma (MFH) has recently been questioned as a distinct clinical entity [2], [3], [4]. Our results do not exclude the possibility that MFH is a collection of mesenchymal tumors derived from different cell types that share an undifferentiated state. However, our finding of a sarcoma geneset conserved between mouse sarcomas and human MFH suggests that this subtype of human sarcoma shares an underlying biology beyond a common histologic appearance. Moreover, the use of cross-species analysis to identify FOXM1 as a marker of metastasis-free survival in human MFH supports the use of this mouse model to understand mechanisms of metastasis, to investigate the cell(s) of origin, and to develop novel therapies for human MFH.
###end p 45
###begin title 46
Supporting Information
###end title 46
###begin p 47
Supplementary Methods
###end p 47
###begin p 48
(0.07 MB DOC)
###end p 48
###begin p 49
Click here for additional data file.
###end p 49
###begin p 50
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Geneset derived from mouse model of synovial sarcoma versus control (normal muscle). Geneset was derived using signal-to-noise metric.
###end p 50
###begin p 51
(0.04 MB DOC)
###end p 51
###begin p 52
Click here for additional data file.
###end p 52
###begin p 53
###xml 88 96 88 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s002">Table S1</xref>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
###xml 172 177 <span type="species:ncbi:9606">human</span>
GSEA results for synovial sarcoma geneset derived from mouse model of synovial sarcoma (Table S1). The mouse synovial sarcoma geneset was used to examine three datasets of human soft tissue sarcomas. Table denotes p-values with FDR in parentheses. Bolded results note significance with p<0.05; FDR<0.25. DNE = Did Not Enrich, dash marks represent insufficient data points to do comparison.
###end p 53
###begin p 54
(0.04 MB DOC)
###end p 54
###begin p 55
Click here for additional data file.
###end p 55
###begin p 56
###xml 29 33 29 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 40 49 40 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 21 49 21 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 50 55 <span type="species:ncbi:10090">mouse</span>
Geneset derived from LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma compared to control (normal muscle). Genes were identified using signal-to-noise metric with the top 100 genes used in the geneset.
###end p 56
###begin p 57
(0.04 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
###xml 16 25 16 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008075-g001">Figure 1c</xref>
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
Geneset used in Figure 1c was derived from Nakayama et al [10] using signal-to-noise metric comparing MFH versus control (other soft tissue sarcomas).
###end p 59
###begin p 60
(0.05 MB DOC)
###end p 60
###begin p 61
Click here for additional data file.
###end p 61
###begin p 62
###xml 144 147 144 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Detwiller1">[9]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 230 239 230 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 211 239 211 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 269 277 269 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s004">Table S3</xref>
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Candidate marker genes of human MFH were identified using differentially expressed genes between human MFH and other sarcomas (T-test, p<0.001) [9]-[10]. This list of genes was then cross referenced against the LSL-KrasG12D; Trp53Flox/Flox soft tissue sarcoma geneset (Table S3) and ten overlapping genes were identified.
###end p 62
###begin p 63
(0.03 MB DOC)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
###xml 36 44 36 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008075.s002">Table S1</xref>
###xml 208 212 208 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008075-Nakayama1">[10]</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 175 180 <span type="species:ncbi:9606">human</span>
The mouse synovial sarcoma geneset (Table S1) shows strong enrichment for human synovial sarcoma (Enrichment Score (ES) = 0.67, Normalized Enrichment Score (NES) = 2.21) in a human soft tissue sarcoma dataset[10] (p = 0.00024; FDR = 0.004).
###end p 65
###begin p 66
(0.21 MB PDF)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 109 114 <span type="species:ncbi:9606">human</span>
Representative immunohistochemistry for A phospho-ERK and B FOXM1 show strong nuclear staining from the same human tumor sample. All scale bars represent 100 microns.
###end p 68
###begin p 69
(9.18 MB PDF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Box and whisker plots of nine candidate genes selected for Q-RT-PCR using an independent set of mouse soft tissue sarcomas (n = 5) and normal muscle samples (n = 3). Relative fold expression determined to lowest expressing normal muscle sample. Significance of differentially expressed genes was determined by two-tailed student's T-test.
###end p 71
###begin p 72
(0.31 MB PDF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
Immunostaining of tissue microarrays (TMAs) for FOXM1 and MELK identifies expression in MFH. Tissue Microarrays (TMAs) containing 214 soft tissue sarcomas were stained for FOXM1 and scored semi-quantitatively. The degree of staining for A FOXM1 (p = 0.0017, non-parametric Mann-Whitney test) and B MELK (p = 0.02, non-parametric Mann-Whitney test) was correlated with MFH.
###end p 74
###begin p 75
(0.20 MB PDF)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Potential biomarker MELK does not correlate with metastasis free survival (p = 0.46) in MFH patients. MFH patients were segregated based on high (3+) or low (0-2+) staining on TMAs and survival of the cohorts was compared by Kaplan-Meier analysis.
###end p 77
###begin p 78
(0.28 MB PDF)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G12D</sup>
###xml 23 32 23 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flox/Flox</sup>
###xml 4 32 4 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSL-Kras<sup>G12D</sup>; Trp53<sup>Flox/Flox</sup></italic>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
The LSL-KrasG12D; Trp53Flox/Flox mouse model of soft tissue sarcoma mimics human undifferentiated pleomorphic sarcoma/Malignant Fibrous Histiocytoma (MFH). A, The gross appearance of mouse sarcomas includes areas of necrosis and hemorrhage. The microscopic appearance of these tumors includes high grade sarcomas with B spindle cells and C more pleomorphic cells with D epitheloid like cells and frequent atypical nuclei (arrow). All scale bars represent 100 microm.
###end p 80
###begin p 81
(1.05 MB JPG)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Cultural characteristics of malignant histiocytomas and fibrous xanthomas.
###end article-title 84
###begin article-title 85
Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
###end article-title 85
###begin article-title 86
Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification.
###end article-title 86
###begin article-title 87
Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?
###end article-title 87
###begin article-title 88
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
A spatially and temporally restricted mouse model of soft tissue sarcoma.
###end article-title 88
###begin article-title 89
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.
###end article-title 89
###begin article-title 90
Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
###end article-title 90
###begin article-title 91
###xml 29 34 <span type="species:ncbi:9606">human</span>
Gene expression profiling of human sarcomas: insights into sarcoma biology.
###end article-title 91
###begin article-title 92
Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
###end article-title 92
###begin article-title 93
Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma.
###end article-title 93
###begin article-title 94
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
###end article-title 94
###begin article-title 95
Adjusting batch effects in microarray expression data using empirical Bayes methods.
###end article-title 95
###begin article-title 96
###xml 32 37 <span type="species:ncbi:9606">human</span>
Oncogenic pathway signatures in human cancers as a guide to targeted therapies.
###end article-title 96
###begin article-title 97
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
A conditional mouse model of synovial sarcoma: insights into a myogenic origin.
###end article-title 97
###begin article-title 98
###xml 39 44 <span type="species:ncbi:9606">human</span>
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
###end article-title 98
###begin article-title 99
###xml 107 115 <span type="species:ncbi:9606">patients</span>
H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
###end article-title 99
###begin article-title 100
###xml 42 47 <span type="species:ncbi:9606">human</span>
H-ras and K-ras gene mutations in primary human soft tissue sarcoma: concomitant mutations of the ras genes.
###end article-title 100
###begin article-title 101
###xml 27 32 <span type="species:ncbi:9606">human</span>
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells.
###end article-title 101
###begin article-title 102
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.
###end article-title 102
###begin article-title 103
FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness.
###end article-title 103
###begin p 104
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 104
###begin p 105
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by the Howard Hughes Medical Institute (TJ) and by KO8 CA 114176 and RO1 CA 138265 (DGK), T32 GM-07171 (JM), and the Maria Garcia-Estrada Foundation (RR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 105

